At #AIDS2024 we’ll be showcasing more real-world data from across our portfolio of medicines, showing the value of having treatment and prevention options that suit the individual needs of people living with #HIV 👉 More on our presence in Munich: https://lnkd.in/eN3mdsXx
ViiV Healthcare
Pharmaceutical Manufacturing
Brentford, England 78,153 followers
We are ViiV Healthcare. Here until HIV & AIDS aren't.
About us
We are ViiV Healthcare: a global specialist HIV company, 100% focused on researching and delivering new medicines and improving access to care for people living with HIV. ViiV Healthcare is an independent company owned by GSK (majority shareholder), Pfizer and Shionogi. To view job opportunities with ViiV Healthcare, please visit the GSK company page: https://www.linkedin.com/company/gsk/jobs Our global headquarters are in Brentford, London UK; with our US headquarters in Research Triangle Park, North Carolina. You can read our Social Media Code of Conduct at: bit.ly/SoMe-VHC
- Website
-
http://www.viivhealthcare.com
External link for ViiV Healthcare
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Brentford, England
- Type
- Public Company
- Founded
- 2009
- Specialties
- HIV and Pharmaceuticals
Locations
Employees at ViiV Healthcare
Updates
-
Attending #AIDS2024 in Person? Make sure to look out for our session on Tuesday 23rd that’s focussed on our mission to #PutPeopleFirst 👀 12:00–13:00 CEST, Room B0b - Attend our sponsored symposium for an unconventional session that asks thought-provoking questions on the importance of people-partnered #HIV care. Don't worry! If you're not attending, keep your eyes peeled for updates on our socials. More about our presence in Munich here: https://lnkd.in/eN3mdsXx
-
-
Ending the #HIV epidemic needs partnership at every level. Working with communities and partners in sub-Saharan Africa to deliver more prevention options for people who could benefit from #PrEP is at the heart of our commitment to achieving a future free from HIV. #EndingHIV #PutPeopleFirst https://lnkd.in/dhAD5Zn6
-
#News for #investors and #media We are presenting over 20 abstracts from our innovative pipeline and portfolio of medicines at #AIDS2024, as well as showcasing our commitment to the #HIV community. International AIDS Society #PutPeopleFirst #EndingHIV https://lnkd.in/gQ_NmJa5
-
Our data at #AIDS2024 will reinforce the need to create new #HIV treatment and prevention options that may allow for less frequent dosing intervals. Find out more about our presence in Munich here: https://lnkd.in/eN3mdsXx International AIDS Society #PutPeopleFirst #WeWontStop
-
HIV Science as Art exhibition is coming to #AIDS2024 in Munich, and we’re proud to support! First premiered at #IAS2023 in Brisbane, HIV Science as Art united 12 artists living with HIV and 12 scientists from around the world to transform scientific advancements into spectacular art, successfully raising over $20,000 AUD for HIV programmes in the Asia Pacific region. This July, we're excited to support Münchner Aids-Hilfe in bringing the exhibition to International AIDS Society conference in Munich! All proceeds from art sales will go towards supporting community HIV programmes in Eastern Europe, Central Asia and Africa. Discover our exciting line-up of 12 artist-scientist pairings this year and learn more about the exhibition on the HIV Science as Art website. https://lnkd.in/gt5JxjEF 📍 Location: Brainlab, Olof-Palme-Straße 9, Munich, Germany 📅 Duration: July 22 - July 25, 2024 ⏰ Hours: Daily from 10 a.m. to 7 p.m
-
What will it take to end the HIV epidemic in Europe? HIV care in Europe has progressed through the decades, but data shows that more must be done to achieve the UNAIDS goal of zero new HIV transmissions by 2030. We partnered with POLITICO, International Association of Providers of AIDS Care, and Cyrus Engerer (He/Him), the MEP for Malta, to explore how the government, civil society, and healthcare industry can collaborate to end the HIV epidemic in Europe and beyond. Read more: https://lnkd.in/eRK5C_i3
-
In order to #EndTheEpidemic, it’s vital we do more to remove the roadblocks preventing equitable access to, and education about, HIV prevention options. In this edition of our joint podcast series with Foreign Policy, our own Randevyn Piérre is joined by Henry Bonsu and Shereen El Feki. Together, they explore the opportunities and challenges that lie ahead for those leading the charge to avert HIV transmission. #WeWontStop 👉 Listen to the full episode here: https://lnkd.in/enr-ssiv
-
At #AIDS2024, we will be showcasing our commitment to producing the next generation of treatment and prevention options for people living with #HIV. Watch the video to find out more from our scientists at Branford and visit our website for more on our activities in Munich. https://lnkd.in/eN3mdsXx International AIDS Society #PutPeopleFirst #EndingHIV #WeWontStop
-
We’re pleased to share that ViiV Healthcare will fund two new fellowships at the University of North Carolina at Chapel Hill, in honor of Dr. Adaora Adimora, a distinguished physician-scientist who made exceptional contributions to the fields of HIV epidemiology and clinical care. During the recent announcement of the fellowships, Vani Vannappagari, ViiV’s Global Head of Epidemiology and Real-World Evidence, said she first met Dr. Adimora while studying for her PhD. Vani described her as a teacher, friend, mentor, and colleague, and then, pausing to remember with a smile, “someone who asked things of us.” Dr. Adimora was a force for good, and we are deeply grateful for her medical contributions and the positive impact she had on the HIV community and our ViiV family. We are honored to help support future physicians, scientists, and epidemiology in her memory. https://lnkd.in/eNGWpSrc
-